These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 25230231)

  • 41. Antigens and Antibodies in Disease With Specifics About CGRP Immunology.
    Taylor FR
    Headache; 2018 Nov; 58 Suppl 3():230-237. PubMed ID: 30187471
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expression and function of calcitonin gene-related peptide (CGRP) receptors in trigeminal ganglia of R192Q Cacna1a knock-in mice.
    Vilotti S; Vana N; Van den Maagdenberg AM; Nistri A
    Neurosci Lett; 2016 May; 620():104-10. PubMed ID: 27021026
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A novel formulation of veggies with potent anti-migraine activity.
    Jain MM; Kumari N; Rai G
    Int J Comput Biol Drug Des; 2015; 8(1):54-61. PubMed ID: 25869319
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Binding and functional pharmacological characteristics of gepant-type antagonists in rat brain and mesenteric arteries.
    Sheykhzade M; Amandi N; Pla MV; Abdolalizadeh B; Sams A; Warfvinge K; Edvinsson L; Pickering DS
    Vascul Pharmacol; 2017 Mar; 90():36-43. PubMed ID: 28192258
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Trigeminovascular Pathway: Role of CGRP and CGRP Receptors in Migraine.
    Edvinsson L
    Headache; 2017 May; 57 Suppl 2():47-55. PubMed ID: 28485848
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Targeting calcitonin gene-related peptide: a new era in migraine therapy.
    Charles A; Pozo-Rosich P
    Lancet; 2019 Nov; 394(10210):1765-1774. PubMed ID: 31668411
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Calcitonin gene-related peptide receptor antagonists: beyond migraine pain--a possible analgesic strategy for osteoarthritis?
    Bullock CM; Kelly S
    Curr Pain Headache Rep; 2013 Nov; 17(11):375. PubMed ID: 24068339
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Is there an inherent limit to the efficacy of calcitonin gene-related peptide receptor antagonists in the acute treatment of migraine? A comment.
    Tfelt-Hansen PC
    J Headache Pain; 2009 Dec; 10(6):389-91. PubMed ID: 19779958
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Therapeutic antibodies against CGRP or its receptor.
    Bigal ME; Walter S; Rapoport AM
    Br J Clin Pharmacol; 2015 Jun; 79(6):886-95. PubMed ID: 25614243
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CGRP in Animal Models of Migraine.
    Wattiez AS; Wang M; Russo AF
    Handb Exp Pharmacol; 2019; 255():85-107. PubMed ID: 30689086
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cortical spreading depression as a site of origin for migraine: Role of CGRP.
    Close LN; Eftekhari S; Wang M; Charles AC; Russo AF
    Cephalalgia; 2019 Mar; 39(3):428-434. PubMed ID: 29695168
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Involvement of G protein-coupled receptor kinase-6 in desensitization of CGRP receptors.
    Aiyar N; Disa J; Dang K; Pronin AN; Benovic JL; Nambi P
    Eur J Pharmacol; 2000 Sep; 403(1-2):1-7. PubMed ID: 10969137
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Calcitonin gene-related peptide (CGRP): role in migraine pathophysiology and therapeutic targeting.
    Wattiez AS; Sowers LP; Russo AF
    Expert Opin Ther Targets; 2020 Feb; 24(2):91-100. PubMed ID: 32003253
    [No Abstract]   [Full Text] [Related]  

  • 54. Regulation of signal transduction by calcitonin gene-related peptide receptors.
    Walker CS; Conner AC; Poyner DR; Hay DL
    Trends Pharmacol Sci; 2010 Oct; 31(10):476-83. PubMed ID: 20633935
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CGRP ligand and receptor monoclonal antibodies for migraine prevention: Evidence review and clinical implications.
    Dodick DW
    Cephalalgia; 2019 Mar; 39(3):445-458. PubMed ID: 30661365
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CGRP receptor antagonists: a new choice for acute treatment of migraine?
    Durham PL
    Curr Opin Investig Drugs; 2004 Jul; 5(7):731-5. PubMed ID: 15298069
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CGRP Receptor Biology: Is There More Than One Receptor?
    Hay DL
    Handb Exp Pharmacol; 2019; 255():13-22. PubMed ID: 29797087
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Receptors for calcitonin gene-related peptide, adrenomedullin, and amylin: the contributions of novel receptor-activity-modifying proteins.
    Born W; Fischer JA; Muff R
    Recept Channels; 2002; 8(3-4):201-9. PubMed ID: 12529937
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Functional calcitonin gene-related peptide receptors are formed by the asymmetric assembly of a calcitonin receptor-like receptor homo-oligomer and a monomer of receptor activity-modifying protein-1.
    Héroux M; Hogue M; Lemieux S; Bouvier M
    J Biol Chem; 2007 Oct; 282(43):31610-20. PubMed ID: 17785463
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacological characterization of MK-0974 [N-[(3R,6S)-6-(2,3-difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide], a potent and orally active calcitonin gene-related peptide receptor antagonist for the treatment of migraine.
    Salvatore CA; Hershey JC; Corcoran HA; Fay JF; Johnston VK; Moore EL; Mosser SD; Burgey CS; Paone DV; Shaw AW; Graham SL; Vacca JP; Williams TM; Koblan KS; Kane SA
    J Pharmacol Exp Ther; 2008 Feb; 324(2):416-21. PubMed ID: 18039958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.